Atrial fibrillation can affect your eyes in several ways, most seriously by sending blood clots into the tiny arteries that supply the retina. When a clot blocks one of these arteries, part or all of your vision in that eye can disappear within seconds. Beyond this direct threat, AFib-related strokes can damage the brain’s visual processing areas, the medications used to treat AFib carry their own eye-related risks, and emerging research suggests that even the irregular blood flow itself may quietly alter the small blood vessels at the back of the eye.
How AFib Sends Clots to the Eye
The most dangerous way AFib affects vision is through a retinal artery occlusion, essentially a stroke of the eye. When the heart beats irregularly, blood can pool in the upper chambers and form clots. If a clot breaks free and travels through the bloodstream, it can lodge in the central retinal artery or one of its branches, cutting off blood supply to the retina. The mechanism is the same one that causes brain strokes, except the clot ends up in the eye instead of the brain.1PubMed Central. Atrial fibrillation in Retinal Artery Occlusions The American Heart Association considers central retinal artery occlusion a form of acute ischemic stroke that causes severe visual loss and signals a heightened risk of further cardiovascular and cerebrovascular events.2Stroke / American Heart Association. Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association
The connection between AFib and retinal artery occlusion runs in both directions, and the numbers are striking. A meta-analysis found that people with AFib had roughly five times the odds of experiencing a central retinal artery occlusion compared to those without the arrhythmia.3Ophthalmologica Indonesiana. The Association between Atrial Fibrillation and Central Retinal Artery Occlusion: A Meta-Analysis and Systematic Review Meanwhile, among people who show up to the emergency room with a central retinal artery occlusion, nearly half are found to have AFib within two years, many of them previously undiagnosed. The rate at which AFib turned up in these patients was comparable to the rate seen after a traditional brain stroke.4PubMed. Detection of Atrial Fibrillation After Central Retinal Artery Occlusion
What makes a retinal artery occlusion so devastating is speed. The retina is one of the most metabolically active tissues in the body, and once its blood supply is cut off, irreversible damage begins within minutes. A person typically notices sudden, painless vision loss in one eye. If only a branch artery is blocked, the vision loss may affect just part of the visual field. If the central artery is blocked, the entire eye goes dark or nearly so. There is no widely accepted acute treatment that reliably restores vision, which is why prevention through managing AFib and stroke risk is so critical.
Temporary Vision Loss as an Early Warning
Not all AFib-related eye events are permanent. Some people experience amaurosis fugax, a brief episode of vision loss in one eye that resolves on its own, usually within minutes. This happens when a small clot temporarily blocks a retinal artery and then breaks apart or passes through. It can feel like a curtain dropping over your vision before lifting again. The episode itself may seem minor, but it is a red flag. A study of patients with this type of ischemic monocular visual loss found that about 9% had AFib, and the researchers noted this was likely an undercount because only about half of the patients had undergone prolonged heart rhythm monitoring.5PubMed. Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?
The practical takeaway here matters: if you experience even a fleeting episode of vision loss in one eye, particularly if it is painless and resolves within a few minutes, get your heart rhythm checked. Many people with AFib have no symptoms like palpitations or shortness of breath. An episode of transient vision loss may be the first clue that the heart is misfiring, and it often precedes a more serious event like a full retinal artery occlusion or a brain stroke.
Retinal Vein Occlusion and AFib
Retinal artery occlusions get most of the attention in the AFib conversation, but there is also evidence linking AFib to retinal vein occlusions. These are different events: instead of a clot blocking blood flow into the retina, a retinal vein occlusion involves impaired drainage of blood out of it. The result is swelling, hemorrhage, and blurred or distorted vision rather than the sudden blackout typical of an artery blockage.
A large nationwide cohort study found that people with retinal vein occlusion had a meaningfully higher rate of developing AFib afterward compared to matched controls. Over the study period, AFib developed in about 6.5% of people with retinal vein occlusion versus 4% of the comparison group, and after adjusting for other cardiovascular risk factors, the association remained significant.6PubMed Central. Evaluation of the Association Between Retinal Vein Occlusion and the Risk of Atrial Fibrillation Development: A 12-Year, Retrospective Nationwide Cohort Study Another cohort study found a higher rate of new AFib among patients with retinal artery occlusions than among those with vein occlusions, but the retinal vein group still showed a somewhat elevated overall rate of new AFib at roughly 1.5 per 100 person-years.7PubMed Central. Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study
The connection between vein occlusions and AFib is less direct than the embolic mechanism behind artery occlusions. Shared cardiovascular risk factors like high blood pressure, diabetes, and vascular disease likely explain a large part of the overlap. Still, if you develop a retinal vein occlusion, your doctor may reasonably want to screen for AFib as part of the cardiovascular workup.
When a Stroke Hits the Visual Brain
AFib is one of the leading causes of ischemic stroke, and roughly a quarter of strokes caused by AFib-related clots affect the posterior circulation, which feeds the occipital lobe at the back of the brain. This is where the brain processes visual information, so damage there can produce visual field defects even though the eyes themselves are perfectly healthy. The most common result is homonymous hemianopia, where you lose vision on the same side in both eyes. If the stroke affects the right occipital lobe, you lose vision on the left side of your visual field, and vice versa.
This kind of vision loss can be disorienting. People often describe bumping into objects on one side or not noticing cars approaching from a particular direction. A study tracking patients with homonymous hemianopia after occipital stroke found that more than three-quarters experienced some spontaneous improvement in their visual fields within six months. Partial defects were more likely to improve than complete ones. After the six-month mark, though, measurements tended to stabilize, with about half the patients showing small ongoing fluctuations but no major further recovery.8PubMed Central. Evolution of Visual Field Defects After Occipital Stroke: A Quantitative Analysis The prospect of partial recovery is encouraging, but prevention, primarily through anticoagulation in people with AFib, remains far better than any post-stroke rehabilitation approach.
Eye Problems Caused by AFib Medications
Managing AFib often requires medications that carry their own risks to the eyes. The three main drug categories worth knowing about are antiarrhythmics, blood thinners, and, less commonly today, digoxin.
Amiodarone and Optic Nerve Damage
Amiodarone is one of the most commonly prescribed antiarrhythmic drugs for AFib, and it has a well-documented tendency to deposit in the cornea, producing a harmless whorl-like pattern in the eye that most patients never notice. The more concerning side effect is optic neuropathy, damage to the optic nerve that can cause progressive visual loss. Patients taking amiodarone have roughly double the risk of developing optic neuropathy compared to people not taking the drug, with the risk appearing higher in men and in people who have been on it longer.9PubMed Central. Amiodarone-Associated Optic Neuropathy: Clinical Review Dronedarone, a related drug sometimes used as an alternative, has also been linked to optic neuropathy, and early recognition of visual symptoms may allow withdrawal of the drug before permanent damage sets in.10PubMed. Presumed Optic Neuropathy after Amiodarone and then Dronedarone for Treatment of Atrial Fibrillation
If you are on amiodarone and notice gradual blurring, dimming of vision, or changes in color perception, bring it up with both your cardiologist and an eye doctor promptly. The corneal deposits alone are rarely a reason to stop the drug, but optic nerve involvement is.
Blood Thinners and Bleeding Inside the Eye
Blood thinners are the cornerstone of stroke prevention in AFib, but thinning the blood also raises the risk of bleeding, including inside the eye. Intraocular hemorrhages, whether in the vitreous, retina, or choroid, can range from a small spot that your eye absorbs on its own to a sight-threatening bleed. A pharmacovigilance analysis found that both warfarin and newer oral anticoagulants like rivaroxaban and dabigatran have been associated with retinal and vitreous hemorrhages, though the specific patterns differ. Warfarin showed a stronger association with choroidal hemorrhage, while rivaroxaban had a higher signal for retinal and vitreous bleeds.11PubMed Central. Risk of intraocular hemorrhage with new oral anticoagulants
The good news is that a meta-analysis of over 100,000 patients found that the newer anticoagulants as a class were associated with about a 22% lower risk of intraocular bleeding compared to warfarin.12PubMed Central. Risk of Intraocular Bleeding With Novel Oral Anticoagulants Compared With Warfarin: A Systematic Review and Meta-analysis This does not mean the newer drugs are risk-free, but it does mean that the shift away from warfarin toward drugs like apixaban and rivaroxaban has likely reduced this particular side effect for many patients. If you suddenly see floaters, flashes, or a dark shadow spreading across your vision while on any blood thinner, seek urgent eye care.
Digoxin and Color Vision Changes
Digoxin is used less often for AFib than it once was, but it is still prescribed for some patients to help control heart rate. One of its well-known toxic effects involves the eyes: xanthopsia, a yellow-tinged distortion of vision. Other visual symptoms of digoxin toxicity include seeing a green tint, flashes of light, light sensitivity, and even visual hallucinations. The reassuring part is that these effects typically resolve within days to weeks once the drug is stopped or the dose is lowered.13PubMed Central. Xanthopsia Due to Digoxin Toxicity as a Cause of Traffic Accidents: A Case Report Because digoxin has a narrow therapeutic window, even small changes in kidney function or hydration can push levels into the toxic range, so any new visual oddity while taking it is worth reporting immediately.
Subtle Changes in the Eye’s Small Blood Vessels
Beyond the dramatic events of artery blockages and bleeding, researchers have been investigating whether AFib causes quieter, more gradual changes to the tiny blood vessels in the retina and the choroid, the vascular layer beneath it. Using advanced retinal imaging, a study of AFib patients undergoing catheter ablation found that while the density of blood vessels in the retinal layers did not change significantly, the choroidal thickness and a measure of choroidal blood volume increased after the procedure, at least in the central foveal region.14PubMed Central. Assessment of retinal and choroidal microcirculatory alterations following radiofrequency catheter ablation in atrial fibrillation patients using swept-source optical coherence tomography angiography
Separate research has explored whether the retina’s microvasculature can serve as a window into what is happening in the brain. In AFib patients, those who also had cerebral microbleeds showed a larger avascular zone at the center of the retina and lower vessel density in the retinal capillary layers compared to AFib patients without brain microbleeds. These retinal changes were strongly associated with the presence of microbleeds after adjusting for other risk factors.15medRxiv. Optical Coherence Tomography-Angiography Metrics in Patients with Atrial Fibrillation and Cerebral Microbleeds This line of research is still early, but it raises the intriguing possibility that a noninvasive retinal scan could someday help flag which AFib patients are at the highest risk of vascular complications in the brain.
Living With Vision Loss After a Retinal Artery Occlusion
For people who do suffer a retinal artery occlusion linked to AFib, the aftermath goes beyond what an eye chart can measure. A study assessing vision-related quality of life found that patients who had experienced a central retinal artery occlusion scored significantly worse than controls across nearly every dimension tested, including general vision, peripheral awareness, the ability to do near and distance tasks, independence from others, social functioning, and mental health related to their vision loss.16PubMed. Assessment of vision-related quality of life in patients with central retinal artery occlusion The loss tends to be sudden and often permanent, and adapting to functional monocular vision, or severe impairment in one eye, requires real adjustment.
Activities that depend on depth perception, like pouring liquids, navigating stairs, or driving, become harder. Many patients describe a persistent sense of vulnerability on the affected side. Support from low-vision rehabilitation specialists, who can teach compensatory strategies and recommend assistive devices, can make a genuine difference in day-to-day function. If you have AFib and have already experienced any form of eye event, making sure your anticoagulation regimen is optimized is one of the most important steps you can take to protect the other eye.
Why Retinal Events in AFib Often Go Underrecognized
One of the frustrating realities in this space is underdiagnosis. AFib is sometimes called a “silent” arrhythmia because many people have it without feeling palpitations or any other cardiac symptoms. Retinal artery occlusions, similarly, are often treated as isolated eye emergencies rather than as signals of a systemic cardiovascular problem. The finding that nearly half of patients with a central retinal artery occlusion turn out to have AFib on extended monitoring suggests that many of these patients are walking around with undetected rhythm problems.4PubMed. Detection of Atrial Fibrillation After Central Retinal Artery Occlusion And the study of ischemic monocular blindness that found only about half of patients had prolonged cardiac monitoring highlights the gap on the other end: even after an eye event, the cardiac workup is sometimes incomplete.5PubMed. Atrial Fibrillation: An Underestimated Cause of Ischemic Monocular Visual Loss?
Closing that gap requires coordination between eye doctors and cardiologists. If you experience sudden vision loss or a transient visual blackout in one eye, an ophthalmologist should evaluate the retina, and a cardiac workup including extended rhythm monitoring should follow. The reverse holds too: if you are diagnosed with AFib, you should know that your eyes are among the organs at risk, and any new visual symptom, whether sudden darkness, persistent blurring, floaters, flashing lights, or a strange color tint, warrants prompt attention. The retina, in a very real sense, offers a direct view of the same vascular system that the heart depends on, and problems showing up there are rarely limited to the eye alone.